Presentation ESC 2024 OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation Presenter: Manesh R. Patel September 01, 2024 REGISTER for free or LOG IN to view this content CAD Pharma Stroke Heart Rhythm Atrial Fibrillation Presentation ESC 2024 Up Next Presentation ESC 2024 Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation Presenter: Dipak Kotecha September 01, 2024 More slides + Presentation ESC 2024 Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Presenter: Pardeep S. Jhund September 01, 2024 Presentation ESC 2024 Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial Presenter: Gi-Byoung Nam September 01, 2024 We Recommend
Presentation ESC 2024 Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation Presenter: Dipak Kotecha September 01, 2024
Presentation ESC 2024 Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis Presenter: Pardeep S. Jhund September 01, 2024
Presentation ESC 2024 Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial Presenter: Gi-Byoung Nam September 01, 2024